Hepregen Company
Hepregen Corporation is a biotechnology company that focuses on understanding the metabolism of drugs in the liver.
Technology:
Cancer, Organ-on-a-chip
Industry:
PharmTech, Providers
Headquarters:
Medford, Massachusetts, United States
Founded Date:
2007-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
3
Total Funding:
4500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2012-06-27
Last Funding Type:
Grant
Register and Claim Ownership